低级别囊性肾上皮性肿瘤患者的长期结局
对1970至2010年间3865例接受肾切除术的患者中145例曾被分类为囊性透明细胞肾细胞癌的标本,按2016年世界卫生组织标准重新分类为多房囊性低恶性潜能肿瘤(MCLMP)、囊性透明细胞肾细胞癌(ccRCC)和囊性透明细胞乳头状肾细胞癌(ccpRCC),并评估长期肿瘤学结局。所有亚型的10年和20年癌症特异性生存率均为100%。
要点
- 145例中MCLMP 18例(12%)、囊性ccRCC 95例(66%)、囊性ccpRCC 32例(22%)。
- MCLMP患者更多为女性且肿瘤更大,与囊性ccRCC和囊性ccpRCC相比。
- 所有亚型10年和20年癌症特异性生存率均为100%。
核心结论
- 在曾被分类为囊性ccRCC的大型队列中,经病理重新审阅和长期随访,MCLMP是低级别囊性肾上皮性肿瘤中最少见的亚型;所有亚型手术切除后长期预后均极好。
研究设计与样本
- 回顾性队列研究:1970至2010年间3865例因单侧散发性ccRCC接受根治性或部分肾切除术的患者中,145例曾被分类为囊性ccRCC,由一名对结局设盲的泌尿生殖病理学家按2016年WHO标准重新审阅并重新分类。
主要发现
- 145例标本中,18例(12%)分类为MCLMP,95例(66%)为囊性ccRCC,32例为囊性ccpRCC(22%)。
- MCLMP患者更多为女性(61% vs 29% vs 31%,P = .03),肿瘤更大(中位4.6 cm vs 3.0 cm vs 2.3 cm,P = .02),分别与囊性ccRCC和囊性ccpRCC相比。
- 仅2%的囊性ccRCC存在肿瘤坏死或3级核仁。
- 幸存者中位随访10.3年(四分位距7.4-14.9)。
- 随访期间共1例MCLMP、5例囊性ccRCC和4例ccpRCC复发;所有亚型10年和20年癌症特异性生存率均为100%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report on the long-term oncologic outcomes of 3 subtypes of low grade cystic renal epithelial neoplasms-multilocular cystic neoplasm of low malignant potential (MCLMP), cystic clear cell RCC (ccRCC), and cystic clear cell papillary RCC (ccpRCC), following 2016 reorganization by the World Health Organization. MATERIALS AND METHODS: A total of 3865 patients underwent radical or partial nephrectomy for unilateral, sporadic ccRCC between 1970 and 2010, of which 145 had previously been classified as cystic ccRCC. One genitourinary pathologist, blinded to outcome, rereviewed and reclassified the specimens by 2016 WHO criteria. Oncologic outcomes were estimated using the Kaplan-Meier method. RESULTS: Of 145 specimens, 18 (12%) were classified as MCLMP, 95 (66%) cystic ccRCC, and 32 (22%) cystic ccpRCC. Those with MCLMP were more likely female (61% vs 29% vs 31%, P = .03) with larger tumors (median 4.6 cm vs 3.0 cm vs 2.3 cm, P = .02) compared to those with cystic ccRCC and cystic ccpRCC, respectively. Only 2% of cystic ccRCC had tumor necrosis or grade 3 nucleoli present. Median follow-up for survivors was 10.3 years (interquartile range 7.4-14.9). Overall, 1 MCLMP, 5 cystic ccRCC, and 4 ccpRCC recurred during follow-up. Ten- and 20-year cancer-specific survival was 100% across all subtypes. CONCLUSION: In a large cohort of patients previously classified as cystic ccRCC with pathologic rereview and long-term follow-up, we noted that MCLMP is the least common subtype of low grade cystic renal epithelial neoplasms. Regardless, all subtypes are associated with an excellent long-term prognosis following surgical resection.
引用
- Westerman ME, Cheville JC, Lohse CM, et al. Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms. Urology. 2019. PMID: 31356826. doi:10.1016/j.urology.2019.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。